NovaBay Pharmaceuticals Stock Forum

For NovaBay, this success could translate into a positive outlook for its stock in 2024 by demonstrating strong revenue growth.
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) stands out, particularly in the realm of eyecare. April 2024 marked a significant milestone for the company, as it announced record-breaking sales of its Avenova-branded products through Amazon.com, its largest sales channel. This achievement is n...

NovaBay Pharmaceuticals Sells DERMAdoctor Skincare Business for $1 Million.
NovaBay Pharmaceuticals Inc. (NYSE: NBY), a leading biopharmaceutical company, has announced a significant business move that could reshape its future operations and financial outlook. The company has entered into an agreement to sell its DERMAdoctor skincare business, including all product inventory, for approximately $1.0 million in ca...